Suppr超能文献

血液透析通路再循环及通路血流量测量方法的比较

A comparison of methods for the measurement of hemodialysis access recirculation and access blood flow rate.

作者信息

Lindsay R M, Bradfield E, Rothera C, Kianfar C, Malek P, Blake P G

机构信息

Optimal Dialysis Research Unit, London Health Sciences Centre, Victoria Campus, Ontario, Canada.

出版信息

ASAIO J. 1998 Jan-Feb;44(1):62-7.

PMID:9466503
Abstract

The ability to accurately measure access recirculation (AR) is of importance because its presence indicates access dysfunction and may explain why a prescribed Kt/V (urea) has not been delivered. The ability to measure access flow (Qa) allows access monitoring and the detection of impending access dysfunction. AR can be measured by indicator dilution or conductivity tracer techniques. Qa calculation is simple if AR can be detected. The previous techniques are used while the patient's blood lines are reversed to induce AR, and the Krivitski equation gives: Qa = Qb [1-r/r] where Qb = dialyzer blood flow and r = proportion of AR induced. Three methods for AR and Qa measurements were directly compared: 1) ultrasound dilution (Transonics Hemodialysis Monitor, Transonics Systems Incorporated) (TRANS); 2) hematocrit dilution (Crit-Line Monitor, In-Line Diagnostics) (CRIT); and 3) differential conductivity (Hemodynamic Monitor, GAMBRO Healthcare Incorporated) (HDM). Patients were cannulated in a standard fashion and dialysis commenced with lines in normal configuration. A HDM test was performed and, if AR = zero, the lines were reversed to induce AR. HDM, TRANS, and CRIT tests for AR were next done in rapid succession for direct comparison. Each test was repeated three times in succession, the device in random order, to assess test repeatability. Qb was taken from the 1) dialysis machine pump, and 2) directly from TRANS and Qa calculated, using 1) and 2) AR results. In comparison to TRANS, AR results were virtually identical for HDM (TRANS AR = 1.04 HDM-AR + 0.02, r = 0.98, p = 0.0000), and good for CRIT (CRIT-AR = 0.84 TRANS-AR - 0.2, r = 0.81, p = 0.001), but CRIT underestimated the values. Repeatability was assessed by normalizing (%) the SD of repeated measurements; values were 7.5% (HDM), 9.1 % (TRANS), and 17.4% (CRIT). Qa value comparisons were similar (minimal r = 0.83) regardless of Qb source, but CRIT overestimated the value; repeatability data showed 10.6% (HDM), 13.0% (TRANS), and 25.2% (CRIT) (n ranged from 15-64). In summary, TRANS and HDM appear equal as far as accuracy and repeatability of measurements; CRIT results correlated well, but tended to underestimate AR and overestimate Qa, and was less reproducible.

摘要

准确测量通路再循环(AR)的能力很重要,因为其存在表明通路功能障碍,并且可以解释为何未达到规定的Kt/V(尿素)值。测量通路血流量(Qa)的能力有助于通路监测以及发现即将出现的通路功能障碍。AR可以通过指示剂稀释法或电导率示踪技术进行测量。如果能够检测到AR,Qa的计算很简单。以前的技术是在患者的血路管反转以诱导AR的情况下使用的,并且克里维茨基方程给出:Qa = Qb [1 - r/r],其中Qb = 透析器血流量,r = 诱导的AR比例。对三种AR和Qa测量方法进行了直接比较:1)超声稀释法(Transonics血液透析监测仪,Transonics系统公司)(TRANS);2)血细胞比容稀释法(Crit-Line监测仪,在线诊断公司)(CRIT);3)微分电导率法(血流动力学监测仪,甘布罗医疗公司)(HDM)。患者以标准方式进行插管,透析开始时血路管处于正常配置。进行HDM测试,如果AR = 0,则反转血路管以诱导AR。接下来依次快速进行HDM、TRANS和CRIT的AR测试以进行直接比较。每个测试连续重复三次,设备顺序随机,以评估测试的可重复性。Qb取自1)透析机泵,以及2)直接取自TRANS并计算Qa,使用1)和2)的AR结果。与TRANS相比,HDM的AR结果几乎相同(TRANS AR = 1.04 HDM - AR + 0.02,r = 0.98,p = 0.0000),CRIT的结果较好(CRIT - AR = 0.84 TRANS - AR - 0.2,r = 0.81,p = 0.001),但CRIT低估了这些值。通过将重复测量的标准差标准化(%)来评估可重复性;值分别为7.5%(HDM)、9.1%(TRANS)和17.4%(CRIT)。无论Qb的来源如何,Qa值的比较相似(最小r = 0.83),但CRIT高估了该值;可重复性数据显示分别为10.6%(HDM)、13.0%(TRANS)和25.2%(CRIT)(n范围为15 - 64)。总之,就测量的准确性和可重复性而言,TRANS和HDM似乎相当;CRIT结果相关性良好,但倾向于低估AR并高估Qa,并且再现性较差。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验